PT - JOURNAL ARTICLE AU - Bharath Ambale-Venkatesh AU - Thiago Quinaglia AU - Mahsima Shabani AU - Jaclyn Sesso AU - Karan Kapoor AU - Matthew B Matheson AU - Colin O Wu AU - Christopher Cox AU - Joao A C Lima TI - Prediction of Mortality in hospitalized COVID-19 patients in a statewide health network AID - 10.1101/2021.02.17.21251758 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.17.21251758 4099 - http://medrxiv.org/content/early/2021/02/19/2021.02.17.21251758.short 4100 - http://medrxiv.org/content/early/2021/02/19/2021.02.17.21251758.full AB - Importance A predictive model to automatically identify the earliest determinants of both hospital discharge and mortality in hospitalized COVID-19 patients could be of great assistance to caregivers if the predictive information is generated and made available in the immediate hours following admission.Objective To identify the most important predictors of hospital discharge and mortality from measurements at admission for hospitalized COVID-19 patients.Design Observational cohort study.Setting Electronic records from hospitalized patients.Participants Patients admitted between March 3rd and August 24th with COVID-19 in Johns Hopkins Health System hospitals.Exposures 216 phenotypic variables collected within 48 hours of admission.Main Outcomes We used age-stratified (<60 and >=60 years) random survival forests with competing risks to identify the most important predictors of death and discharge. Fine-Gray competing risk regression (FGR) models were then constructed based on the most important RSF-derived covariates.Results Of 2212 patients, 1913 were discharged (age 57±19, time-to-discharge 9±11 days) while 279 died (age 75±14, time to death 14±15 days). Patients >= 60 years were nearly 10 times as likely to die within 60 days of admission as those <60. As the pandemic evolved, the rate of hospital discharge increased in both older and younger patients. Incident death and hospital discharge were accurately predicted by measures of respiratory distress, inflammation, infection, renal function, red cell turn over and cardiac stress. FGR models for each of hospital discharge and mortality as outcomes based on these variables performed well in the older (AUC 0.80-0.85 at 60-days) and younger populations (AUC >0.90 at 60-days).Conclusions and Relevance We identified markers collected within 2 days of admission that predict hospital discharge and mortality in COVID-19 patients and provide prediction models that may be used to guide patient care. Our proposed model suggests that hospital discharge and mortality can be forecasted with high accuracy based on 8-10 variables at this stage of the COVID-19 pandemic. Our findings also point to several specific pathways that could be the focus of future investigations directed at reducing mortality and expediting hospital discharge among COVID-19 patients. Probability of hospital discharge increased over the course of the pandemic.Question Can we predict the likelihood of hospital discharge as well as mortality from data obtained in the first 48 hours from admission in hospitalized COVID-19 patients?Findings Models based on extensive phenotyping mined directly from electronic medical records followed by variable selection, accounted for the competing events of hospital death versus discharge, predicted both death and discharge with area under the receiver operating characteristic curves of >0.80.Meaning Hospital discharge and mortality can be forecasted with high accuracy based on just 8-10 variables, and the probability of hospital discharge increased over the course of the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors of the study are partially or fully was funded by various grants from the National Heart, Lung and Blood Institute and the National Institute of Aging (National Institutes of Health, USA). The funders had no role in the design, data analysis, data interpretation, or writing the report.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted at Johns Hopkins Hospital, Baltimore, Maryland; Bayview Hospital, Baltimore, Maryland; Howard County General Hospital, Columbia, Maryland; Suburban Hospital, Bethesda, Maryland; and Sibley Hospital, Washington, DC. These 5 hospitals comprise Johns Hopkins Medicine (JHM), a health care system serving approximately 7 million persons in the Maryland-Washington DC area. The institutional review boards of each of these hospitals approved this study as minimal risk and waived consent requirements. Clinical data from COVID-19 patients admitted to all 5 Hopkins hospitals in the state of Maryland are entered in the same electronic medical record (EPIC) system and housed under the Johns Hopkins Crown Program, part of the Precision Medicine Institutional Initiative. Data management and curation are supervised by the C.A.D.R.E. data security group which treats each request for data access in a case by case process composed of several regulatory layers dealing with different aspects of data management including; data security, curation, scientific merit and ethical soundness. Authorization was provided by the CADRE committee for data access for the research presented here.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe Authors are responsible for the accuracy and integrity of the entire set of results and are willing to provide, after IRB consent, the datasets and code used in the analysis at any time as requested.